Effects of Pridopidine on Functional Capacity in Early-Stage Participants from the PRIDE-HD Study

BACKGROUND: No pharmacological treatment has been demonstrated to provide a functional benefit for persons with Huntington’s disease (HD). Pridopidine is a sigma-1-receptor agonist shown to have beneficial effects in preclinical models of HD. OBJECTIVE: To further explore the effect of pridopidine o...

Descripción completa

Detalles Bibliográficos
Autores principales: McGarry, Andrew, Leinonen, Mika, Kieburtz, Karl, Geva, Michal, Olanow, C. Warren, Hayden, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836066/
https://www.ncbi.nlm.nih.gov/pubmed/33164941
http://dx.doi.org/10.3233/JHD-200440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836066/
https://www.ncbi.nlm.nih.gov/pubmed/33164941
http://dx.doi.org/10.3233/JHD-200440

Ejemplares similares